First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2009-03-31 14:54:37Open Document File Size: 203,93 KBShare Result on FacebookCompanyGlaxoSmithKline / Ames / /CountryUnited States / /Currencypence / /EventProduct Issues / FDA Phase / /IndustryTermpredominant product / chemical / healthcare / food / /MedicalConditiontoxic megacolon / intestinal obstruction / abdominal pain / thrombophlebitis / resolved constipation / Carcinogenesis / mouse lymphoma cell / IBS abdominal pain / Crohn’s disease / fecal incontinence / severe constipation / severe diarrhea-predominant irritable bowel syndrome / ischemic colitis / ileus / ulcerative colitis / pain / frequent and severe abdominal pain / diarrhea / hypersensitivity / bloody diarrhea / end-stage renal disease / less tiredness / constipation / irritable bowel syndrome / Hepatic Insufficiency / /MedicalTreatmentblood transfusion / antibiotics / surgery / /OrganizationConcomitant administration / Food and Drug Administration / DOSAGE AND ADMINISTRATION / / /PositionCounsel / Patient-Physician / enrolled physician / physician / treating physician / Major / /Productlevonorgestrel / estradiol / itraconazole / theophylline / LOTRONEX / Ketoconazole / clarithromycin / cimetidine / isoniazid / S-012 / intestinal circulation / 3A4 / CYP drug / thrombophlebitis / CYP1A2 / /PublishedMediumthe Medication Guide / /TechnologyPharmacokinetics / DNA synthesis / Pharmacodynamics / /URLwww.lotronex.com / /SocialTag |